SYNERGISTIC ANTITUMOR INTERACTIONS BETWEEN PANOBINOSTAT AND CONVENTIONAL CHEMOTHERAPY DRUGS IN HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Wang, G. [1 ]
Jolly, P. [2 ]
Taub, J. [1 ]
Ge, Y. [2 ]
Wang, Z. [1 ]
机构：
[1] Wayne State Univ, Childrens Hosp Michigan, Detroit, MI USA
[2] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [21] The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
    Groh, Tomas
    Hrabeta, Jan
    Khalil, Mohammed Ashraf
    Doktorova, Helena
    Eckschlager, Tomas
    Stiborova, Marie
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (01) : 343 - 352
  • [22] The Impact of Improving Nutrition During Induction Chemotherapy in Children with High-Risk Neuroblastoma
    Carroll, C.
    Smith, A.
    Clinton, F.
    Ryan, A.
    Capra, M.
    Pears, J.
    Owens, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S288 - S288
  • [23] Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells
    Grossmann, Liron D.
    Chen, Chia-Hui
    Uzun, Yasin
    Thadi, Anusha
    Wolpaw, Adam J.
    Louault, Kevin
    Goldstein, Yael
    Surrey, Lea F.
    Martinez, Daniel
    Calafatti, Matteo
    Gerelus, Mark
    Gao, Peng
    Lee, Lobin
    Patel, Khushbu
    Kaufman, Rebecca S.
    Shani, Guy
    Farrel, Alvin
    Moshitch-Moshkovitz, Sharon
    Grimaldi, Paris
    Shapiro, Matthew
    Kendsersky, Nathan M.
    Lindsay, Jarrett M.
    Casey, Colleen E.
    Krytska, Kateryna
    Scolaro, Laura
    Tsang, Matthew
    Groff, David
    Matkar, Smita
    Kalna, Josh R.
    Mycek, Emily
    Mcdevitt, Jayne
    Runbeck, Erin
    Patel, Tasleema
    Bernt, Kathrin M.
    Asgharzadeh, Shahab
    Declerck, Yves A.
    Mosse, Yael P.
    Tan, Kai
    Maris, John M.
    CANCER DISCOVERY, 2024, 14 (12) : 2387 - 2406
  • [24] Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction
    Cupit-Link, Margaret
    Federico, Sara M.
    CANCERS, 2023, 15 (18)
  • [25] Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma
    Carr, J
    Challen, C
    Board, J
    Wood, KM
    Pearson, ADJ
    Lunec, J
    Tweddle, DA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S54 - S54
  • [26] Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
    Mayampurath, Anoop
    Ramesh, Siddhi
    Michael, Diana
    Liu, Liu
    Feinberg, Nicholas
    Granger, Meaghan
    Naranjo, Arlene
    Cohn, Susan L.
    Volchenboum, Samuel L.
    Applebaum, Mark A.
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 1181 - 1188
  • [27] The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children*
    Van Heerden, Jaques
    Geel, Jennifer
    Hendricks, Marc
    Wouters, Kristien
    Buchner, Ane
    Naidu, Gita
    Hadley, G. P.
    Du Plessis, Jan
    Van Emmenes, Barry
    Van Zyl, Anel
    Vermeulen, Johani
    Kruger, Mariana
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (04) : 300 - 313
  • [28] Targeted Gold Nanoclusters for Synergistic High-Risk Neuroblastoma Therapy through Noncanonical Ferroptosis
    Xue, Liyuan
    Luo, Kaidi
    Hou, Kaixiao
    Huo, Wendi
    Ruan, Panpan
    Xue, Yilin
    Yao, Xiuxiu
    Meng, Cong
    Xia, Dongfang
    Tang, Yuhua
    Zhao, Wencong
    Yuan, Hui
    Zhao, Liang
    Gao, Liang
    Yuan, Qing
    Gao, Xueyun
    Cao, Kai
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (40) : 53555 - 53566
  • [29] Synergistic efficacy of CK2 inhibitor with common chemotherapy drugs by restoring Ikaros function in high-risk ALL
    Song, Chunhua
    Ge, Zheng
    Gowda, Chandrika
    Ding, Yali
    Payne, Jonathon
    Tan, Bihua
    Cury, Nathalia M.
    Dovat, Elanora
    Zhao, Zhijun
    Lyu, Xiaoguang
    McGrath, Mary
    Desai, Dhimant
    Lyer, Soumya
    Raju, Pavan K. Dhanyam
    Payne, Kimberly J.
    Dovat, Sinisa
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma
    Whittle, Sarah B.
    Williamson, Kaitlin C.
    Russell, Heidi V.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (05) : 331 - 342
12345